Arsenal Medical Announces Results of Novel Translational Research Study Determining Human Dose for its Trauma Foam ...

Arsenal Medical, Inc. today announced the completion of a novel, multi-center translational research study of the company’s trauma foam technology, an intervention designed to slow traumatic internal bleeding in patients, which would potentially allow them to survive long enough to reach a hospital and undergo surgery.



from Content Keyword RSS http://ift.tt/1IC5ZAz

via IFTTT